Showing results (1301-1310 of 3,153) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|June 21, 2022
Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cellsXueran Chen, Wanxiang Niu, Xiaoqing Fan, et al.Neuro-Oncology|January 23, 2023
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cellsHeng Liu, Cheng Xu, Bill H Diplas, et al.Neuro-Oncology|January 7, 2023
Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with gliomaGeno Guerra, Lucie McCoy, Helen M Hansen, et al.Neuro-Oncology|January 11, 2021
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastomaJorge A Benitez, Darren Finlay, Anthony Castanza, et al.Neuro-Oncology|January 12, 2021
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastomaShaofang Wu, Xiaolong Li, Feng Gao, et al.Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.Neuro-Oncology|June 2, 2021
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastomaKent A Riemondy, Sujatha Venkataraman, Nicholas Willard, et al.Neuro-Oncology|December 16, 2020
Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicityYi Liu, Zhongjun Li, Maolei Zhang, et al.Neuro-Oncology|May 31, 2022
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trialJosé Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez, et al.Neuro-Oncology|December 19, 2022
Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosisMargarita Zaytseva, Andge Valiakhmetova, Ludmila Yasko, et al.Pageof 316